KYBELLA

KYBELLA® is the first and only drug that is FDA approved for the treatment of submental fullness. KYBELLA® is design to approve appearance and profile of moderate to severe fat below the chin (submental fat), also called “double chin.”KYBELLA® sharpen the jawline thus improve the patient's profile. KYBELLA® also defines and contours the lower face. The safety and effectiveness of KYBELLA® for the treatment of fat outside of the submental area or in children under 18 years of age has not been studied..

 

 

place-holder.png

QUICK TIPS:

  • Non surgical

  • Results are permanent

  • Results are visible 4-6 weeks post treatment 

  • Patients should expect immediate swelling that may last up to 2 weeks post treatment